Literature DB >> 26902429

Phenotypic and Functional Characterization of Mesenchymal Stem/Multipotent Stromal Cells From Decidua Parietalis of Human Term Placenta.

Mohamed H Abumaree1, F M Abomaray2, N A Alshehri3, A Almutairi4, A S AlAskar3, B Kalionis5, M A Al Jumah3.   

Abstract

Mesenchymal stem/multipotent stromal cells (MSCs) from the human placenta show stem cell-like properties useful for regenerative medicine. Previously, we reported that MSCs isolated from the fetal part of human term placentae have characteristics, which make them a potential candidate for regenerative medicine. In this study, we characterized MSC isolated from the maternal part of human term placenta. The MSCs were isolated from the decidua parietalis (DPMSCs) of human placenta using a digestion method and characterized by colony-forming unit assay and the expression of MSC markers by flow cytometry technique. In addition, DPMSC differentiation into the 3 mesenchymal lineages was also performed. Moreover, the gene and protein expression profiles of DPMSCs were identified by real-time polymerase chain reaction and flow cytometry techniques, respectively. Furthermore, proteins secreted by DPMSCs were detected by sandwich enzyme-linked immunosorbent assays. Finally, the proliferation and migration potentials of DPMSCs were also determined. The DPMSCs were positive for MSC markers and negative for hematopoietic and endothelial markers, as well as costimulatory molecules and HLA-DR. Functionally, DPMSCs formed colonies and differentiated into chondrocytes, osteocytes, and adipocytes. In addition, they proliferated and migrated in response to different stimuli. Finally, they expressed and secreted many biological and immunological factors with multiple functions. Here, we carry out an extensive characterization of DPMSCs of human placenta. We report that these cells express and secrete a wide range of molecules with multiple functions, and therefore, we suggest that these cells could be an attractive candidate for cell-based therapy.
© The Author(s) 2016.

Entities:  

Keywords:  decidua parietalis mesenchymal stem cells; migration; placenta; proliferation

Mesh:

Substances:

Year:  2016        PMID: 26902429     DOI: 10.1177/1933719116632924

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  18 in total

1.  Comparison of the Biological Characteristics of Mesenchymal Stem Cells Derived from the Human Placenta and Umbilical Cord.

Authors:  Mingjun Wu; Ruifan Zhang; Qing Zou; Yaoyao Chen; Min Zhou; Xingjie Li; Ran Ran; Qiang Chen
Journal:  Sci Rep       Date:  2018-03-22       Impact factor: 4.379

2.  Cancer Conditioned Medium Modulates Functional and Phenotypic Properties of Human Decidua Parietalis Mesenchymal Stem/Stromal Cells.

Authors:  E Bahattab; T Khatlani; F M Abomaray; S A Messaoudi; M H Abumaree
Journal:  Tissue Eng Regen Med       Date:  2019-11-01       Impact factor: 4.169

Review 3.  Stem Cell Therapy Potency in Personalizing Severe COVID-19 Treatment.

Authors:  Arefeh Basiri; Fatemeh Mansouri; Arezo Azari; Parviz Ranjbarvan; Fateme Zarein; Arash Heidari; Ali Golchin
Journal:  Stem Cell Rev Rep       Date:  2021-01-28       Impact factor: 5.739

4.  Characterization of the interaction between human decidua parietalis mesenchymal stem/stromal cells and natural killer cells.

Authors:  M H Abumaree; E Bahattab; A Alsadoun; A Al Dosaimani; F M Abomaray; T Khatlani; B Kalionis; M F El-Muzaini; A O Alawad; A S AlAskar
Journal:  Stem Cell Res Ther       Date:  2018-04-12       Impact factor: 6.832

5.  Comparative separation methods and biological characteristics of human placental and umbilical cord mesenchymal stem cells in serum-free culture conditions.

Authors:  Xiao Yi; Feng Chen; Fenghua Liu; Qing Peng; Yang Li; Shao Li; Jiang Du; Yi Gao; Yifeng Wang
Journal:  Stem Cell Res Ther       Date:  2020-05-19       Impact factor: 6.832

6.  Preconditioning human natural killer cells with chorionic villous mesenchymal stem cells stimulates their expression of inflammatory and anti-tumor molecules.

Authors:  M H Abumaree; N A Alshehri; A Almotery; A M Al Subayyil; E Bahattab; F M Abomaray; T Khatlani; B Kalionis; D Jawdat; M F El-Muzaini; M A Al Jumah; A S AlAskar
Journal:  Stem Cell Res Ther       Date:  2019-02-06       Impact factor: 6.832

7.  Preconditioning of Human Decidua Basalis Mesenchymal Stem/Stromal Cells with Glucose Increased Their Engraftment and Anti-diabetic Properties.

Authors:  Yasser Basmaeil; Manar Al Rashid; Tanvir Khatlani; Manal AlShabibi; Eman Bahattab; Meshan L Abdullah; Fawaz Abomaray; Bill Kalionis; Safia Massoudi; Mohammad Abumaree
Journal:  Tissue Eng Regen Med       Date:  2020-02-19       Impact factor: 4.169

Review 8.  Allogenic Use of Human Placenta-Derived Stromal Cells as a Highly Active Subtype of Mesenchymal Stromal Cells for Cell-Based Therapies.

Authors:  Raphael Gorodetsky; Wilhelm K Aicher
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

Review 9.  Perspective of placenta derived mesenchymal stem cells in acute liver failure.

Authors:  Mahshid Saleh; Mohammad Taher; Amir Ali Sohrabpour; Amir Abbas Vaezi; Mohsen Nasiri Toosi; Maria Kavianpour; Zeinab Ghazvinian; Shahrokh Abdolahi; Javad Verdi
Journal:  Cell Biosci       Date:  2020-05-24       Impact factor: 7.133

10.  Clinical applications of mesenchymal stromal cell-based therapies for pulmonary diseases: An Update and Concise Review.

Authors:  Xiaobo Chen; Feng Wang; Zhiwei Huang; Yan Wu; Jie Geng; Yuliang Wang
Journal:  Int J Med Sci       Date:  2021-06-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.